Pharmacology of oxidative stress: translational opportunities

Andreas Daiber; Fabio Di Lisa; Péter Ferdinandy

doi:10.1111/bph.13795

Pharmacology of oxidative stress: translational opportunities

Br J Pharmacol. 2017 Jun;174(12):1511-1513. doi: 10.1111/bph.13795.

Authors

Andreas Daiber¹, Fabio Di Lisa², Péter Ferdinandy^{3

4}

Affiliations

¹ University Medical Center Mainz, Center for Cardiology, Molecular Cardiology, Mainz, Germany.
² Department of Biomedical Sciences and CNR Neuroscience Institute, University of Padova, Padova, Italy.
³ Pharmahungary Group, Szeged, Hungary.
⁴ Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.

Abstract

This article is part of a themed section on Redox Biology and Oxidative Stress in Health and Disease. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.12/issuetoc.

Publication types

Editorial
Introductory Journal Article
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Antioxidants / pharmacology*
Cardiovascular Diseases / drug therapy*
Cardiovascular Diseases / metabolism
Humans
Metabolic Diseases / drug therapy*
Metabolic Diseases / metabolism
Nervous System Diseases / drug therapy*
Nervous System Diseases / metabolism
Oxidation-Reduction
Oxidative Stress / drug effects*
Reactive Nitrogen Species / metabolism
Reactive Oxygen Species / metabolism

Substances

Antioxidants
Reactive Nitrogen Species
Reactive Oxygen Species